Document is current
Any future updates will be listed below
-
Authors
Maddaluno, Luigi https://orcid.org/0000-0002-4325-6220
Urwyler, Corinne
Rauschendorfer, Theresa
Meyer, Michael
Stefanova, Debora
Spörri, Roman
Wietecha, Mateusz
Ferrarese, Luca
Stoycheva, Diana
Bender, Daniela
Li, Nick
Strittmatter, Gerhard
Nasirujjaman, Khondokar https://orcid.org/0000-0002-0562-968X
Beer, Hans‐Dietmar https://orcid.org/0000-0002-8085-713X
Staeheli, Peter
Hildt, Eberhard
Oxenius, Annette
Werner, Sabine https://orcid.org/0000-0001-7397-8710
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_169204 and 310030B_189364)
ETH Zurich (ETH-06 15-1)
European Commission (Marie Curie Fellowship)
Swiss Government (Excellence Fellowship)
- License Information
-
More Information
Article History
Received: 20 November 2019
Revised: 27 June 2020
Accepted: 30 June 2020
First Online: 27 July 2020
Conflict of interest
: L.M., M.M., and S.W. have filed a patent for the use of FGFR inhibitors in antiviral defense (Filing No. EP3308786A1). There are no additional competing interests of any of the authors.
